Feasibility and effectiveness of second-line chemotherapy with mitomycin C in patients with advanced penile cancer
{{output}}
Background: Triple-drug cisplatin- and taxane-based chemotherapy is the standard treatment for metastatic penile squamous cell cancer (PeSCC), with a moderate response rate of 30% to 38%. Relapse after first-line chemotherapy has... ...
